IDPH Reports No Illinois Counties at an Elevated Community Level for COVID-19
ILLINOIS, May 5 - Data Reporting to Change at End of Public Health Emergencies on May 11
IDPH has recorded a total of 4,135,808 cases and 36,850 deaths, in 102 counties in Illinois since the beginning of the pandemic. The department is reporting 3,850 new confirmed and probable cases of COVID-19 in Illinois in the week ending April 30, and 5 deaths.
IDPH Director Dr. Sameer Vohra welcomed the news today that the World Health Organization has declared an end to the global health emergency for COVID-19 that was in place since January 30, 2020. Director Vohra said that with the national and state Public Health Emergencies for COVID -19 expiring on May 11, there will be changes to data collection and reporting on the virus:
- After May 11, the CDC has announced it will stop tracking and reporting COVID-19 cases at the community level, meaning that it will no longer be providing a weekly updates that show whether COVID-19 cases are at Low, Medium or High Level.
- Hospitals will no longer be required to report the number of COVID-19 patients in hospital beds or in the ICU or on ventilators.
- IDPH will continue to report the weekly number of COVID-19 hospital admissions, cases and deaths and weekly vaccination data.
"We want the public to know that due to changes in federal reporting requirements some of the COVID-19 data that we have been collecting will change after May 11," said IDPH Director Dr. Sameer Vohra. "However, IDPH will still have reliable methods for tracking COVID-19 in Illinois. IDPH will continue its focus on protecting the public from COVID-19, especially those individuals who are vulnerable to serious illness. With the World Health Organization's news today of the end of the global health emergency, as well as the national public health emergency and statewide disaster declarations ending in less than a week, it is very good news that cases remain low. All counties in Illinois are now at Low Community Level for COVID-19 and this marks the seventh straight week with zero counties at a high COVID-19 community level."
Both IDPH and the Illinois Department on Aging have endorsed recommendations earlier this month by the FDA and CDC for an optional additional updated bivalent vaccine dose for adults 65 and older and optional additional doses for people who are immunocompromised. The bivalent booster is designed to offer better protection against newer strains of the virus.
On April 19, the CDC recommended a second bivalent booster for those who are 65 and older if it has been at least four months since their first bivalent booster. For those who are immunocompromised, they are eligible for a second bivalent booster if it has been at least two months since their first bivalent booster.
IDPH is helping Illinoisans stay prepared for any future surge of COVID-19 cases by offering 1 million free COVID-19 rapid antigen tests to Illinois residents in all zip codes outside the City of Chicago through a partnership with the Rockefeller Foundation's public charity, RF Catalytic Capital and its Project ACT (Access COVID Tests) program.
The CDC previously authorized two new bivalent booster vaccines on September 1 that include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an added mRNA component in common between the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant.
Initially, the Moderna COVID-19 Vaccine, Bivalent, was recommended for use as a single booster dose in individuals 18 years of age and older and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 12 years of age and older. On October 12, the CDC authorized the updated COVID-19 vaccines from Pfizer-BioNTech for children ages 5 through 11 years, and from Moderna for children and adolescents ages 6 through 17 years.
On December 9, the CDC expanded its authorization for bivalent boosters to include children aged 6 months to 5 years. On March 14, the FDA expanded its authorization for bivalent boosters to include children aged 6 months to 4 years who had previously completed their entire Pfizer primary series with the monovalent vaccine. For young children, multiple doses of bivalent vaccine continue to be recommended and will vary by age, vaccine, and which vaccines were previously received.
Under the new recommendations, children 6 months through 5 years of age who are unvaccinated may receive a two-dose series of the Moderna bivalent vaccine (6 months through 5 years of age) OR a three-dose series of the Pfizer-BioNTech bivalent vaccine (6 months through 4 years of age). Children who are 5 years of age may receive two doses of the Moderna bivalent vaccine or a single dose of the Pfizer-BioNTech bivalent vaccine.
Children 6 months through 5 years of age who have received one, two or three doses of a monovalent COVID-19 vaccine may receive a bivalent vaccine, but the number of doses that they receive will depend on the vaccine and their vaccination history.
As of last night, 404 individuals in Illinois were reported to be in the hospital with COVID-19. Of those, 46 patients were in the ICU and 25 patients with COVID-19 were on ventilators. The preliminary seven-day statewide case rate is 31 COVID-19 cases per 100,000 Illinoisans.
In counties at the Medium Community Level, persons who are elderly or immunocompromised (at risk of severe outcomes) are advised to wear a mask in indoor public places. They should also get up to date on COVID-19 vaccines or get their bivalent booster, if eligible.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.